Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Noxxon Pharma patents new nucleic acid molecules

July 31, 2013

FDA accepts tasimelteon NDA for priority review

July 31, 2013

Depomed acquires Lazanda nasal spray

July 31, 2013

FDA grants orphan drug status to Convergence Pharmaceuticals' CNV-1014802

July 31, 2013

CereSpir signs letter of intent to acquire rights to Chiesi's CHF-5074

July 30, 2013

Novel sleep deprivation-induced animal model for Alzheimer's disease described

July 30, 2013

Neuren reports data for NNZ-2591 from fragile X model

July 30, 2013

uniQure begins phase I trial of gene therapy for Parkinson's disease

July 30, 2013

Eisai receives positive CHMP opinion for Zonegran in pediatric patients

July 30, 2013

A novel CNTF-derived peptide restores cognitive impairment in vivo

July 30, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...